Evidence map›Paper›PMID 38243259›Full record

ReviewRespiratory research2024

Malignant pleural effusion: current understanding and therapeutic approach.

Francesca Gonnelli, Wafa Hassan, Martina Bonifazi, Valentina Pinelli, Eihab O Bedawi, José M Porcel, Najib M Rahman, Federico Mei

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Respiratory research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07208409 (How Small Is Small - Pleurodesis in Small-Bore Chest Tube), which is not on this map. Cited by 65 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 3 pooled it
28.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07208409 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

How Small Is Small - Pleurodesis in Small-Bore Chest Tube

TypeinterventionalSponsorThe University of Hong KongRan2026 to 2029Enrolled60ConditionsPleural Effusion, MalignantArms14 Fr chest tube, 12 Fr chest tube, 8 Fr chest tube
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 3 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Comparison of LENT, PROMISE, and RECLS scores in malignant pleural effusions.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Intrapleural anti-PD-1 antibody for the treatment of advanced non-small cell lung cancer with malignant pleural effusion: a prospective, single-arm, single-center, phase I trial.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  17. Article
  18. Review
  19. Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Francesca GonnelliDepartment of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona Via Conca 71, Ancona, 60126, Italy.
Wafa HassanDepartment of Respiratory Medicine, Sheffield Teaching Hospitals, University of Sheffield, Sheffield, UK.
Martina BonifaziDepartment of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona Via Conca 71, Ancona, 60126, Italy.
Valentina PinelliPulmonology Unit, San Bartolomeo Hospital, Sarzana, Italy.
Eihab O BedawiDepartment of Respiratory Medicine, Sheffield Teaching Hospitals, University of Sheffield, Sheffield, UK.
José M PorcelResearch Group of Cancer Biomarkers, Lleida Institute for Biomedical Research Dr. Pifarré Foundation (IRBLleida), Lleida, Spain.
Najib M RahmanOxford Pleural Unit, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.
Federico MeiDepartment of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona Via Conca 71, Ancona, 60126, Italy. federico.mei@ospedaliriuniti.marche.it.
Marche Polytechnic University · ITUniversity of Sheffield · GBBiomedical Research Institute of Lleida · ESOxford BioMedica (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant pleural effusion (MPE) is a common complication of thoracic and extrathoracic malignancies and is associated with high mortality and elevated costs to healthcare systems. Over the last decades the understanding of pathophysiology mechanisms, diagnostic techniques and optimal treatment intervention in MPE have been greatly advanced by recent high-quality research, leading to an ever less invasive diagnostic approach and more personalized management. Despite a number of management options, including talc pleurodesis, indwelling pleural catheters and combinations of the two, treatment for MPE remains symptom directed and centered around drainage strategy. In the next future, because of a better understanding of underlying tumor biology together with more sensitive molecular diagnostic techniques, it is likely that combined diagnostic and therapeutic procedures allowing near total outpatient management of MPE will become popular. This article provides a review of the current advances, new discoveries and future directions in the pathophysiology, diagnosis and management of MPE.

Indexed as

Pleural Effusion, MalignantCatheters, IndwellingDrainageHumansPleurodesisTalcTalcChest drainIndwelling pleural catheter (IPC)Malignant pleural effusion (MPE)OncologyPleuralPleurodesisThoracoscopy

Identifiers

PMID38243259
PMCPMC10797757
OpenAlexW4391026875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.